Dr. Colin Lindsay, a Clinical Senior Lecturer in Medical Oncology at the Christie NHS Foundation Trust, adeptly manages a dual focus on groundbreaking research and compassionate patient care. His academic journey commenced at the CRUK Beatson Institute in Glasgow, where he earned a PhD under the guidance of Owen Sansom. During this period, Dr. Lindsay delved into the exploration of genetically modified mouse models of RAS and RAF-driven melanoma.

Having transitioned to the realm of lung cancer translation, Dr. Lindsay actively participated in the CRUK Stratified Medicine Programme. He further enriched his expertise through a two-year ESMO translational fellowship at the Gustave Roussy Institute in Villejuif, France, working alongside Benjamin Besse and Jean-Charles Soria. His primary research thrust revolves around the implementation of effective treatment strategies for RAS-driven cancers and the translation of genomic findings to achieve optimal clinical impact.

In his capacity, Dr. Lindsay is deeply involved in the treatment of non-small cell lung cancer and small cell lung cancer. He actively engages in NHS clinics and ward rounds while also assuming leadership roles as a principal and co-investigator for phase II and III clinical trials. Dr. Lindsay plays a pivotal role in shaping the landscape of lung cancer care through active participation in multi-disciplinary meetings for the Greater Manchester central sector.

Beyond his clinical responsibilities, Dr. Lindsay is dedicated to advancing cancer research for the University of Manchester. He collaborates with esteemed institutions such as the Cancer Research UK Manchester Institute and CRUK at the Crick Institute in London. Currently, Dr. Lindsay is instrumental in establishing translational research links in lung cancer, organising a clinical trials portfolio, and contributing to practice-changing studies that introduce promising new drugs.